These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22731756)

  • 1. Cell therapy in critical limb ischemia: current developments and future progress.
    Mamidi MK; Pal R; Dey S; Bin Abdullah BJ; Zakaria Z; Rao MS; Das AK
    Cytotherapy; 2012 Sep; 14(8):902-16. PubMed ID: 22731756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal.
    Lawall H; Bramlage P; Amann B
    Thromb Haemost; 2010 Apr; 103(4):696-709. PubMed ID: 20174766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies.
    Qadura M; Terenzi DC; Verma S; Al-Omran M; Hess DA
    Stem Cells; 2018 Feb; 36(2):161-171. PubMed ID: 29226477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic angiogenesis in the management of critical limb ischemia: current concepts and review.
    Attanasio S; Snell J
    Cardiol Rev; 2009; 17(3):115-20. PubMed ID: 19384084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic angiogenesis for critical limb ischemia.
    Ko SH; Bandyk DF
    Semin Vasc Surg; 2014 Mar; 27(1):23-31. PubMed ID: 25812756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of VEGF secreted from stromal cells in supporting endothelial cell functions: therapeutic implications for critical limb ischemia.
    Cobellis G; Maione C; Botti C; Coppola A; Silvestroni A; Lillo S; Schiavone V; Molinari AM; Sica V
    Cell Transplant; 2010; 19(11):1425-37. PubMed ID: 20587143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia.
    Bura A; Planat-Benard V; Bourin P; Silvestre JS; Gross F; Grolleau JL; Saint-Lebese B; Peyrafitte JA; Fleury S; Gadelorge M; Taurand M; Dupuis-Coronas S; Leobon B; Casteilla L
    Cytotherapy; 2014 Feb; 16(2):245-57. PubMed ID: 24438903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia.
    Beltrán-Camacho L; Rojas-Torres M; Durán-Ruiz MC
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wireless laser-assisted angioplasty of the superficial femoral artery in patients with critical limb ischemia who have failed conventional percutaneous revascularization.
    Boccalandro F; Muench A; Sdringola S; Rosales OR
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):7-12. PubMed ID: 15343560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical limb ischaemia.
    Minar E
    Hamostaseologie; 2009 Jan; 29(1):102-9. PubMed ID: 19151858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies for cell-based neovascularization in critical limb ischemia.
    Samura M; Hosoyama T; Takeuchi Y; Ueno K; Morikage N; Hamano K
    J Transl Med; 2017 Feb; 15(1):49. PubMed ID: 28235425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic angiogenesis using zinc oxide nanoflowers for the treatment of hind limb ischemia in a rat model.
    Barui AK; Nethi SK; Basuthakur P; Jhelum P; Bollu VS; Reddy BR; Chakravarty S; Patra CR
    Biomed Mater; 2021 Mar; 16(4):. PubMed ID: 33657534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach.
    Berndt R; Hummitzsch L; Heß K; Albrecht M; Zitta K; Rusch R; Sarras B; Bayer A; Cremer J; Faendrich F; Groß J
    Stem Cell Res Ther; 2018 Apr; 9(1):117. PubMed ID: 29703251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical limb ischemia: does long-term patency matter?
    Jaffery Z; Grant AG; White CJ
    Vasc Med; 2010 Dec; 15(6):439-41. PubMed ID: 20965958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging hurdles in stem cell therapy for peripheral vascular disease.
    Aranguren XL; Verfaillie CM; Luttun A
    J Mol Med (Berl); 2009 Jan; 87(1):3-16. PubMed ID: 18712330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI).
    Shirbaghaee Z; Heidari Keshel S; Rasouli M; Valizadeh M; Hashemi Nazari SS; Hassani M; Soleimani M
    Stem Cell Res Ther; 2023 Jul; 14(1):174. PubMed ID: 37408043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment.
    Sprengers RW; Teraa M; Moll FL; de Wit GA; van der Graaf Y; Verhaar MC; ;
    J Vasc Surg; 2010 Oct; 52(4):843-9, 849.e1. PubMed ID: 20598482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia.
    Mutirangura P; Ruangsetakit C; Wongwanit C; Chinsakchai K; Porat Y; Belleli A; Czeiger D
    J Med Assoc Thai; 2009 Mar; 92(3):320-7. PubMed ID: 19301723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-based therapies in patients with critical limb ischemia.
    Kitrou P; Karnabatidis D; Brountzos E; Katsanos K; Reppas L; Spiliopoulos S
    Expert Opin Biol Ther; 2017 Apr; 17(4):449-456. PubMed ID: 28133976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell therapy in PAD.
    Sprengers RW; Moll FL; Verhaar MC
    Eur J Vasc Endovasc Surg; 2010 Mar; 39 Suppl 1():S38-43. PubMed ID: 20153223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.